Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

photo of grains and niacin supplement pills

Link Discovered Between Excess Niacin and Cardiovascular Disease

Newly identified pathway may explain the so-called niacin paradox

photo of cardiologists working in a cardiac catheterization lab

New AHA Statement Clarifies Cath Lab Role in Out-of-Hospital Cardiac Arrest

Guidance on the often-fatal condition through an interventional cardiology lens

illustration of heart and lungs with text

Vital Statistics in Adult Cardiac Surgery, Valve Surgery and Aorta Surgery

Check out our latest volume and outcomes data in these key areas

illustration of mitral valve with male/female symbol overlay

Long-Term Outcomes of Mitral Valve Repair for Degenerative MR Worse in Women Than Men

A call for surgical guidelines to adopt sex-specific thresholds of LV size and function

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-HVI-4469361_atrial-fibrillation_650x450

Atrial Fibrillation Guideline Introduces Stage-Based Classification, Stresses Early Rhythm Control

ACC/AHA panel also upgrades catheter ablation recommendations

Koji Hashimoto, MD, and team
February 2, 2024/Digestive/Research

Combined Cardiac Surgery and Liver Transplant Is a New Option for Highly Selected Patients

New research indicates feasibility and helps identify which patients could benefit

23-HVI-4475649 CQD 650×450

Low Mortality Is Possible in Elective Multivalve Cardiac Reoperations

Volume-based experience and judicious patient selection are central to success

photo of an ablation procedure in an electrophysiology lab

Pulsed-Field Ablation: A New, Highly Selective Catheter Ablation Method for Heart Arrhythmias

Nonthermal method promises faster procedure times, less risk to adjacent structures

illustration of femoropopliteal bypass with the DETOUR system

Pooled 2-Year Outcomes of DETOUR Trials Support Percutaneous Transfemoral Arterial Bypass

Larger data set confirms safety, efficacy and durability for SFA lesions over 20 cm

19-HVI-1792159; Steven Nissen, M.D., M.A.C.C.; Mike Viars

Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk

It's time to increase testing for this major cardiovascular risk factor in advance of new therapies

BackPage 17 of 63Next

Advertisement

Ad